Skip to main content

Sight Sciences, Inc.

SGHT
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001531177

No open-market purchases or sales by Sight Sciences, Inc. insiders were filed in the last 90 days; 112 institutions reported holding it in 13F filings for Q2 2026, worth $118.5M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Sight Sciences, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of SGHT: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders65650
Shares16.7M16.6M−130.0K (−0.8%)
Value$86.2M$87.6M+$1.39M (+1.6%)

New holders (12)

Institutions that held Sight Sciences, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Sold out (12)

Institutions that held Sight Sciences, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of SGHT in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Palo Alto Investors LP173,790$896.8K
RTW Investments, LP164,806$850.4K
Bank of Montreal123,500$691.6K
Susquehanna International Group, LLP85,903$443.3K
Marshall Wace, LLP47,513$245.2K
Voya Investment Management LLC36,001$185.8K
Balyasny Asset Management LLC22,639$116.8K
XTX Topco Ltd14,115$72.8K
Wolverine Trading, LLC14,019$72.3K
AQR Capital Management LLC10,950$56.5K
Prelude Capital Management, LLC10,355$53.4K
Advisor Group Holdings, Inc.275$1.42K